Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study

New York University, New York

Mount Sinai, New York

University of Rochester, Rochester

University of Pittsburgh, Pittsburgh

University of Virginia, Charlottesville

Vanderbilt University, Nashville

Cleveland Clinic, Cleveland

University of Kansas Medical Center, Kansas City

University of Colorado Denver, Aurora

Swedish, Seattle